# Bristol-Myers Squibb (BMY) — Analyst Forecast

BMY · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/bmy/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 13, 2026 | Wells Fargo | Maintained | Equal-Weight | $60.00 |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | $53.00 |
| Oct 7, 2026 | Morgan Stanley | Maintained | Underweight | $41.00 |
| Oct 5, 2026 | Leerink Partners | Downgraded | Outperform → Market Perform | $59.00 |
| Sep 16, 2026 | Piper Sandler | Maintained | Overweight | $82.00 |
| Sep 10, 2026 | HSBC | Maintained | Hold | $65.00 |
| Aug 5, 2026 | Argus Research | Upgraded | Hold → Buy | $75.00 |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | $70.00 |
| Jul 31, 2026 | Truist Securities | Maintained | Buy | $70.00 |
| Jul 31, 2026 | Guggenheim | Maintained | Buy | $75.00 |
| Jul 31, 2026 | Wells Fargo | Maintained | Equal-Weight | $65.00 |
| Jul 31, 2026 | Cantor Fitzgerald | Maintained | Neutral | $59.00 |
| Jul 31, 2026 | JP Morgan | Maintained | Overweight | $73.00 |
| Jul 31, 2026 | RBC Capital | Maintained | Sector Perform | $64.00 |
| Jul 10, 2026 | B of A Securities | Maintained | Buy | $66.00 |
| Jul 6, 2026 | Cantor Fitzgerald | Maintained | Neutral | $54.00 |
| Apr 9, 2026 | B of A Securities | Maintained | Buy | $67.00 |
| Apr 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | $54.00 |
| Apr 8, 2026 | Guggenheim | Maintained | Buy | $72.00 |
| Mar 17, 2026 | HSBC | Maintained | Hold | $60.00 |

## Frequently Asked Questions

### What is the latest analyst rating on BMY?

On Oct 13, 2026, Wells Fargo maintained Bristol-Myers Squibb at Equal-Weight with a price target of $60.00.

## Similar Stocks

- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock
- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [AMGN](https://www.lighthorse.io/tickers/amgn) — Amgen Inc. - Common Stock
- [LLY](https://www.lighthorse.io/tickers/lly) — Eli Lilly and Company Common Stock
- [GILD](https://www.lighthorse.io/tickers/gild) — Gilead Sciences, Inc. - Common Stock
- [EXEL](https://www.lighthorse.io/tickers/exel) — Exelixis, Inc. - Common Stock
- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).